Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2388 (LINC02388) is a non-coding RNA gene classified as a long intergenic non-coding RNA (lincRNA), which means it is a transcript greater than 200 nucleotides in length that does not code for a protein and does not overlap annotated protein-coding genes. lincRNAs represent a substantial portion of the human transcriptome and participate in diverse regulatory processes including chromatin remodeling, transcriptional regulation, and serving as molecular scaffolds for proteins and nucleic acids. The biological function of LINC02388 specifically has not been characterized in the literature, and there is no current evidence that it is a direct target of therapeutic drugs or used as a clinical biomarker. As is typical of lincRNAs, roles are likely to be regulatory and may be context-specific, but further research is needed to clarify the function and relevance of LINC02388 in health and disease.
No drugs known to directly modulate LINC02388 or its activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2388 (LINC02388).